Senate Bill Ensures Equal Treatment for Medical Cannabis Users in Employment Policies

The recent government meeting held by the Utah League of Cities and Towns on March 29, 2024, focused on significant legislative updates regarding medical cannabis and drug testing policies for government entities. Key discussions centered around ensuring equitable treatment for medical cannabis users in the workplace.

Senator Escamilla and Representative Ward highlighted the importance of aligning policies for medical cannabis cardholders with those for users of legally controlled substances. The proposed legislation mandates that any adverse employment actions—such as dismissal, suspension, or failure to promote—against employees who test positive for cannabis or hold a medical cannabis card must follow a comprehensive policy. This policy must ensure that these individuals are treated equally to those using prescription medications.

Before any adverse action can be taken against an employee solely based on their status as a cannabis cardholder, employers are required to consult with their city attorney and obtain approval from the mayor. This measure aims to prevent potential legal violations and ensure that actions taken are justified and compliant with existing laws.

Additionally, the meeting addressed House Bill 411, which clarifies that government entities are permitted to use both oral and urine drug tests for employees, volunteers, and prospective employees. This bill requires the adoption of a written policy or ordinance prior to implementing any drug testing procedures.

These legislative updates reflect a growing recognition of the need for fair treatment of medical cannabis users in the workplace while balancing the requirements of federal regulations and workplace safety. The discussions indicate a commitment to creating a more inclusive environment for all employees, regardless of their medical needs.